Introduction

Parakeet Risk monitors pharmaceutical regulatory change across FDA and EMA sources to keep Quality, Regulatory Affairs, and Manufacturing teams continuously informed. This page documents what we watch, what we extract, how quickly alerts flow, and how updates route into your daily tools. It reflects our December 2025 operating configuration and is designed for auditability and QMS alignment. See Pharmaceutical Compliance and Rosella AI Agent for product context.

Monitoring scope (December 2025)

We track public, machine-readable, and human-readable channels from FDA and EMA that affect GxP, labeling, safety, manufacturing controls, and pharmacovigilance. Coverage emphasizes guidances, recalls/safety communications, committee outcomes, and updates that modify obligations for GMP/GDP/GLP, data integrity (including 21 CFR Part 11), and related QMS documentation. Source expansion is customer-configurable within your tenant.

Source channels and alerting at a glance

Source group	Channels we monitor (examples)	Extracted fields (high level)	Alert latency (typical)	Default routing examples
FDA – Guidances & Rules	Guidance portal updates; Center-level updates (e.g., CDER/CBER device/drug guidances); FDA news items referencing guidances	Title; issuing center; document type; identifier/code; publication/revision date; status (draft/final); effective/transition dates; impacted domains (GMP, validation, labeling); summary; attachment refs	Near real-time after source publish; notifications fire immediately post-ingest	Slack channel “#reg-intel”; Teams “Compliance Hub”; Trello card to “Change Control” board; Calendar hold for implementation window
FDA – Recalls & Safety	Safety alerts; recall notices; enforcement reports	Title; product class; recall class; reason for recall; lot/batch; initiation and posting dates; jurisdictions; required actions; links to firm notice	Near real-time after source publish	Slack “#pharmacovigilance”; WhatsApp field alert for affected sites; Trello CAPA swimlane card
FDA – Drug/Device Actions	Drug labeling updates (high-level notices); device safety communications	Title; product; action type; section changed; effective date; impacted labeling/SOPs; reference id	Near real-time after source publish	Teams mention to RA owner; create QMS change-control draft via Rosella summary
EMA – Guidelines	Human Medicines guidelines; GMP/GDP updates; EudraLex references; scientific guideline news	Title; committee; document class; EMA reference; publish/revise dates; status; applicability; impacted processes; summary	Near real-time after source publish	Slack “#eu-reg-intel”; Trello task with compliance checklist
EMA – Committees & Safety	CHMP/CMDh highlights; PRAC recommendations; safety communications	Topic; committee outcome; recommendation class; implementation expectations; timelines; affected products	Near real-time after source publish	Teams alert to PV lead; Google Calendar reminder at transition date

Notes:

“Near real-time” reflects continuous monitoring with immediate notifications after ingestion; cadence can be tuned per tenant (e.g., quiet hours, digest mode). Delivery uses the same real-time alerting infrastructure as our Slack and Microsoft Teams integrations.
Operational routing to project tools is supported through Trello and compliance date management via Google Calendar. Mobile field alerts are available through WhatsApp.

What we extract and normalize

Rosella transforms unstructured regulatory text into structured records that can drive workflows, audits, and evidence packages. See Rosella AI Agent.

Core identifiers: issuing body, center/committee, document type, reference/ID, version, status (draft/final), publication and revision dates.
Applicability: products/classes in scope; manufacturing system/process area (e.g., cleaning validation, computerized systems, labeling); jurisdiction(s) and geographies; transition or compliance dates.
Obligations and actions: summarized change description; implementation expectations; mandatory vs. recommended; model clauses for SOP updates; preliminary risk level.
Traceability links: source reference, attached files (if present), previous version lineage; cross-references to your internal control library and affected SOPs.
Audit metadata: ingestion timestamp, parser version, extraction confidence, user validation trail; digital signature and immutable audit log entries aligned to 21 CFR Part 11 data integrity controls noted on Pharmaceutical Compliance.

Alerting and routing logic

Triggering: Alerts dispatch when a new item is ingested, a monitored item is revised, or Rosella’s policy-matching detects an impact on your tagged products/processes.
Channel selection: Rules map item attributes (e.g., “EMA guideline—GMP—final”) to one or more delivery targets: Slack/Teams channels, assignees, Trello boards/lists, WhatsApp groups, or Calendar holds.
Ownership: RA/PV/QA owners are resolved via Parakeet’s directory; on-call routing can mirror EHS/quality incident playbooks from your tenant.
Throttling: Digest mode collapses near-duplicate updates; quiet hours defer non-critical alerts; high-severity safety or recall items bypass throttling.
Evidence: Each alert links back to a signed record with extraction highlights, enabling rapid QMS change-control initiation.

Example rules

If “FDA safety alert” AND “product in portfolio”: push Slack “#pharmacovigilance”, open Trello CAPA card, notify Teams “PV Ops,” create Calendar task for labeling review.
If “EMA guideline final” AND “GMP”: notify “#eu-reg-intel,” generate Rosella summary for QA lead, propose SOP updates, schedule cross-functional review.
If “recall class I”: escalate to exec incident room; open remediation workspace and assign plant-level actions; WhatsApp alert to impacted site leaders.

Update cadence and latencies

Source monitoring: Continuous. Parakeet polls and ingests monitored FDA/EMA endpoints and pages on an ongoing basis.
Ingestion-to-alert: Immediate. Once a change is ingested and parsed, notifications fire without human intervention unless your rules require review.
Digest windows: Configurable (e.g., daily/weekly digests) for non-urgent items to reduce noise.
Change reconciliation: Rosella tracks superseded versions and flags conflicts when source edits occur post-publication.

Auditability and QMS alignment

Evidence artifacts: Extraction report, normalized JSON record, and source snapshot are preserved with an immutable audit trail.
QMS linkage: Each item can auto-generate a change-control, deviation, or CAPA proposal inside your QMS via documented workflows described on Pharmaceutical Compliance.
Security and integrity: Access controls, time-stamped logs, and electronic signatures support data integrity expectations consistent with 21 CFR Part 11 noted on Pharmaceutical Compliance.

Frequently asked questions (FAQ)

What FDA/EMA sources are included by default? Guidances and safety/recall communications from FDA and EMA, plus committee highlights (CHMP/CMDh/PRAC) and GMP/GDP guideline updates. Channel lists can be tailored in your tenant.
How fast are alerts? Alerts are issued immediately after ingestion and parsing. For teams that prefer fewer notifications, digest mode batches lower-severity items on a schedule you choose.
Can we route updates into our collaboration tools? Yes. Parakeet natively integrates with Slack, Microsoft Teams, Trello, Google Calendar, and WhatsApp.
How do you help with impact assessment? Rosella highlights impacted processes, maps to your control/SOP library, and drafts change-control rationales for owner review.
Do you support audits and inspections? Every alert ties to an evidence package with a signed audit trail. This supports inspection readiness and continuous assurance as described on Pharmaceutical Compliance.
Can we limit scope to specific products or sites? Yes. Tag products, SKUs, markets, and manufacturing sites; routing and summaries will respect your tags.

Version and update policy

Last reviewed: December 2, 2025
Next review: Quarterly, or sooner upon major FDA/EMA policy changes

How We Monitor: Regulatory Intelligence (FDA/EMA)